|
2026 Journal Article A Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake BehaviorShah, Ayesha, Talley, Nicholas J., Knowles, Simon R., Duncanson, Kerith, Koloski, Natasha, Connor, Jason P., Day, Andrew S., Almehdawy, Basil, Basnayake, Chamara, Burgell, Rebecca, Carey, Sharon, Cock, Charles, Daker, Charlotte, Kaushik, Vishal, Kent, Dan, Kellar, Trina, Lane, Katherine, Martin, Neal, Malcolm, Allison, Murphy, Kate Elizabeth, Sharp, Gemma, Tuck, Caroline, Jones, Michael, Thapar, Nikhil and Holtmann, Gerald (2026). A Clinical Practice Update for the Management of Patients With Disorders of Gut-Brain Interaction and Altered Food Intake Behavior. Neurogastroenterology and Motility, 38 (5) e70337. doi: 10.1111/nmo.70337 |
|
2026 Journal Article Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULEShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE. Gastroenterology, 170 (6), S-2458. doi: 10.1016/s0016-5085(26)05815-4 |
|
2026 Journal Article Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULEShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE. Gastrointestinal Endoscopy, 103 (5), S-2458. doi: 10.1016/s0016-5107(26)05746-9 |
|
2026 Journal Article Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIALBredenoord, Albert J., Nguyen, Nam Q., Ho, Vincent, Ko, Hin Hin, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Kolisnik, Tyler, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1101 DURABILITY OF DYSPHAGIA IMPROVEMENTS FOLLOWING SINGLE ADMINISTRATION OF EP-104GI IN PARTICIPANTS WITH EOSINOPHILIC ESOPHAGITIS DURING DOSE ESCALATION IN THE RESOLVE TRIAL. Gastrointestinal Endoscopy, 103 (5), S-817. doi: 10.1016/s0016-5107(26)02132-2 |
|
2026 Journal Article Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUPShah, Ayesha, Moy, Naomi, Kulin, Dmitrii, Callaghan, Gavin, Fairlie, Thomas, Virgo, Kate, Hansen, Teressa J., Jones, Michael P., Koloski, Natasha A., Thapar, Nikhil and Holtmann, Gerald (2026). Sa1759 DISORDERS OF GUT-BRAIN INTERACTION PRESENTING WITH SEVERELY ALTERED FOOD INTAKE BEHAVIOR (DGBI-AFIB): CHARACTERISATION OF A DISTINCT PATIENT GROUP. Gastroenterology, 170 (6), S-1850. doi: 10.1016/s0016-5085(26)04460-4 |
|
2026 Journal Article Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKSGonsalves, Nirmala, Nguyen, Nam Q., Ko, Hin Hin, Ho, Vincent, Afif, Waqqas, Holtmann, Gerald J., Dellon, Evan S., Ravikumar, Pranali, Dye, Andrew, Malone, Amanda and Kowalski, Mark M. (2026). Tu1102 SINGLE ADMINISTRATION OF EP-104GI IN RESOLVE, A PHASE 1B/2 TRIAL IN EOSINOPHILIC ESOPHAGITIS, IMPROVES ENDOSCOPIC FEATURES OF INFLAMMATION AND FIBROSIS OVER 36 WEEKS. Gastroenterology, 170 (6), S-817. doi: 10.1016/s0016-5085(26)02202-x |
|
2026 Journal Article Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSISKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Tu1669 CHRONIC GASTROINTESTINAL SYMPTOMS AND SYSTEMIC COMORBIDITIES IN ADULT PATIENTS WITH HYPERMOBILITY SPECTRUM DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology, 170 (6), S-1946. doi: 10.1016/s0016-5085(26)04668-8 |
|
2026 Journal Article Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation DisordersShah, Ayesha and Holtmann, Gerald (2026). Ready for Prime Time? Breath Testing to Diagnose Intestinal Dysbiosis and Guide Management in Patients With Functional Defecation Disorders. Neurogastroenterology and Motility, 38 (4) e70275. doi: 10.1111/nmo.70275 |
|
2026 Journal Article Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trialLong, Millie, Allegretti, Jessica R, Danese, Silvio, Germinaro, Matthew, Baker, Thomas, Alvarez, Yelina, Kavalam, Mary, Han, Chenglong, Jörgens, Silke, Jiang, Lingjing, Zhang, Hongyan, Hisamatsu, Tadakazu, Rubin, David T, Peyrin-Biroulet, Laurent, Abu-Farsakh, Niazy, Al-Rousan, Lawrence, An, Ping, Argollo, Marjorie, Arguelles Arias, Federico, Augustyn, Monika, Baert, Filip, Balderramo, Domingo, Banerjee, Rupa, Baum, Curtis, Bermudez Villegas, Emilio, Blanco, Antonio, Bortlik, Martin, Bouhnik, Yoram, Soledad Brunatto, Luciana ... Zou, Duowu (2026). Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. The Lancet Gastroenterology and Hepatology, 11 (4), 284-298. doi: 10.1016/S2468-1253(25)00322-X |
|
2026 Journal Article Exercise capacity and neuromuscular fitness in people with disorders of gut-brain interaction (DGBI)Bell, Katherine, Kulin, Dmitrii, McAllister, Sarah, Cougan, Rhiannon, O'Brien, Jake, West, Dale, Shah, Ayesha, Koloski, Natasha, Nicol, Jennifer, Holtmann, Gerald and Coombes, Jeff (2026). Exercise capacity and neuromuscular fitness in people with disorders of gut-brain interaction (DGBI). Journal of Clinical Exercise Physiology, 15 (s2), 225-225. doi: 10.31189/2165-7629-15-s2.225 |
|
2026 Journal Article Gastrointestinal symptoms and systemic comorbidities in patients with POTS : a systematic review and meta‐analysisKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Staller, Kyle, Nurko, Samuel, Keefer, Laurie, Aziz, Qasim, Drossman, Douglas A., Jones, Michael P. and Holtmann, Gerald (2026). Gastrointestinal symptoms and systemic comorbidities in patients with POTS : a systematic review and meta‐analysis. Neurogastroenterology & Motility, 38 (4) e70305, 1-13. doi: 10.1111/nmo.70305 |
|
2026 Journal Article symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interactionColomier, Esther, Jones, Michael P., Holvoet, Lieselot, Van den Houte, Karen, Van de Bruaene, Cedric, Broeders, Bert, Bai, Tao, Liu, Jinsong, Melchior, Chloé, Gourcerol, Guillaume, Chuah, Kee-Huat, Hui, Khoo Xin, Mahadeva, Sanjiv, Ho Siah, Kewin Tien, Lipták, Peter, Banovcin, Peter, Holtmann, Gerald, Koloski, Natasha, Carabotti, Marilia, Annibale, Bruno, Suzuki, Hidekazu, Sano, Masaya, Ueda, Takashi, Hajihashemi, Parisa, Shahoon, Hassan, Adibi, Payman, Simrén, Magnus, Gwee, Kok-Ann, Tack, Jan and Carbone, Florencia (2026). symptom patterns outside the rome iv consensus in eastern and western patients with a disorder of gut-brain interaction. American Journal of Gastroenterology, Publish Ahead of Print 10.14309/ajg.0000000000003996. doi: 10.14309/ajg.0000000000003996 |
|
2026 Journal Article Measuring lifetime alcohol exposure: a scoping review and implications for translational research and alcohol‐related harmPalmer, Andrew J., Connor, Jason P., Holtmann, Gerald, Saunders, John B., Rice, Katie, Yeo, Jeremy, Huang, Andrea and Clark, Paul J. (2026). Measuring lifetime alcohol exposure: a scoping review and implications for translational research and alcohol‐related harm. Addiction, 121 (3), 472-487. doi: 10.1111/add.70208 |
|
2026 Journal Article Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forwardGrady, John, Johnson, Kevin M., Kellermayer, Richard, Winter, Harland S., Tabibian, James H., Buness, Cynthia W., Fischer, Ryan, Shah, Ayesha, Dulai, Parambir S., Rangnekar, Amol S., Alrabadi, Leina, Shah, Shamita B., Holtmann, Gerald, Räisänen, Laura, Lewindon, Peter and Ali, Ahmad H. (2026). Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward. Expert Review of Gastroenterology & Hepatology, 20 (3) 17474124.2026.2635420, 233-246. doi: 10.1080/17474124.2026.2635420 |
|
2026 Journal Article Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasiaJacob, Ronen Ben, Fairlie, Thomas, Talley, Nicholas J., Taylor, Andrew, Frankel, Adam, Smithers, B. Mark, Pandolfino, John E., Jones, Michael P., Hourigan, Luke F., Shah, Ayesha and Holtmann, Gerald (2026). Disorders of gut–brain interaction (DGBI) symptoms and response to peroral endoscopic myotomy in patients with achalasia. Neurogastroenterology and Motility, 38 (1) e70223, 1-11. doi: 10.1111/nmo.70223 |
|
2025 Journal Article Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory studyMarinucci, Nicole, Koloski, Natasha, Baker, Kate, Moy, Naomi and Holtmann, Gerald (2025). Key recommendations to improve equity and access in colorectal cancer screening for rural and remote communities. a grounded theory study. Australian and New Zealand Journal of Public Health, 49 (6) 100295, 100295. doi: 10.1016/j.anzjph.2025.100295 |
|
2025 Journal Article Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux diseaseKoloski, N. A., Jones, M. P., Shah, A., Holtmann, G. and Talley, N. J. (2025). Evidence for brain‐to‐gut and gut‐to‐brain pathways in primary care patients with disorders of gut‐brain interaction, inflammatory bowel disease and gastroesophageal reflux disease. Neurogastroenterology and Motility, 37 (12) e70117, e70117. doi: 10.1111/nmo.70117 |
|
2025 Journal Article Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel DiseasesMoniruzzaman, Md, Shah, Ayesha, Fairlie, Thomas, Keely, Simon, Burns, Grace L., Talley, Nicholas and Holtmann, Gerald (2025). Immune Activation in Primary Sclerosing Cholangitis: A Systematic Review and Comparative Analysis With Inflammatory Bowel Diseases. United European Gastroenterology Journal, 13 (9) ueg2.70115, 1-14. doi: 10.1002/ueg2.70115 |
|
2025 Journal Article Randomized, placebo‐controlled, double‐blind 8‐week trial on the efficacy of a proprietary kiwifruit extract on constipation‐predominant irritable bowel syndromeHoltmann, Gerald, Talley, Nicholas J., Nandurkar, Sanjay and Gibson, Peter R. (2025). Randomized, placebo‐controlled, double‐blind 8‐week trial on the efficacy of a proprietary kiwifruit extract on constipation‐predominant irritable bowel syndrome. JGH Open, 9 (8) e70250, e70250. doi: 10.1002/jgh3.70250 |
|
2025 Journal Article Investigating participation in the Australian National Bowel Cancer Screening Program through general practice: a survey on practices, challenges and digital opportunitiesMarinucci, Nicole, Koloski, Natasha, Whaley, Amanda, Bagnall, Rachael, Shah, Ayesha, Goodwin, Belinda and Holtmann, Gerald (2025). Investigating participation in the Australian National Bowel Cancer Screening Program through general practice: a survey on practices, challenges and digital opportunities. Public Health Research and Practice, 35 (3) PU24017, 1-8. doi: 10.1071/pu24017 |
